Is Erectile Dysfunction a Reliable Proxy of General Male Health Status? The Case for the International Index of Erectile Function-Erectile Function Domain
Overview
Reproductive Medicine
Urology
Authors
Affiliations
Introduction: Erectile dysfunction (ED) has emerged progressively as a sentinel marker of cardiovascular disease (CVD). The correlation between ED and the burden arising from multiple comorbid conditions has been incompletely analyzed.
Aim: Assess whether erectile function, defined with the International Index of Erectile Function-Erectile Function (IIEF-EF) domain score, is associated with health-significant comorbidities scored with the Charlson comorbidity index (CCI).
Methods: Clinical and hemodynamic variables of the last 140 consecutive patients who underwent penile color Doppler ultrasonography for new-onset ED were considered. Patients were assessed with a thorough medical and sexual history. Health-significant comorbidities were scored with the CCI.
Main Outcome Measure: Descriptive statistics and either linear or logistic regression models tested the association among IIEF-EF, hemodynamic parameters, and CCI, which was included in the model both as continuous and categorized variable (0 vs. ≥1).
Results: Complete data were available for 138 patients (98.6%) (mean age 46.6 years [standard deviation 13.0]; range 21-75 years). CCI was 0, 1, and ≥2 in 94 (68.1%), 23 (16.7%), and 21 (15.25%) patients, respectively. Of all, 35 patients (79.5%) did not have a CVD comorbidity. Mean IIEF-EF was 13.7 (9.3). ED severity was no ED, mild, mild to moderate, moderate, and severe in 12 (9.1%), 28 (20.2%), 12 (9.1%), 23 (16.2%), and 63 (45.5%) patients, respectively. At multivariable linear regression analysis, CCI significantly worsened with increased age (β=0.33; P=0.001) and decreased IIEF-EF values (β=-0.25; P=0.01). At logistic regression analysis, age (odds ratio [OR]: 1.05; P=0.004) and IIEF-EF (OR: 0.95; P=0.04) emerged as significant predictors of categorized CCI.
Conclusions: Severity of ED, as objectively interpreted with IIEF-EF, accounts for a higher CCI, which may be considered a reliable proxy of a lower general male health status regardless of the etiology of ED.
Mei Y, Chen Y, Wang X, Xu R, Xu R, Feng X Front Endocrinol (Lausanne). 2025; 15():1442904.
PMID: 39741880 PMC: 11685050. DOI: 10.3389/fendo.2024.1442904.
Wang Q, Guo Y, Zhang H, Qin X, Zhang C, Zhou W BMC Urol. 2024; 24(1):205.
PMID: 39300493 PMC: 11411836. DOI: 10.1186/s12894-024-01579-5.
Baturu M, Bayrak O, Ozturk M, Kurt Y, Serefoglu E Investig Clin Urol. 2024; 65(5):473-479.
PMID: 39249920 PMC: 11390270. DOI: 10.4111/icu.20240200.
Wu X, Zhang Y, Zheng X Front Endocrinol (Lausanne). 2024; 15:1436043.
PMID: 39129923 PMC: 11310141. DOI: 10.3389/fendo.2024.1436043.
High prevalence of erectile dysfunction in men with hyperthyroidism: a meta-analysis.
Liu X, Wang Y, Ma L, Wang D, Peng Z, Mao Z BMC Endocr Disord. 2024; 24(1):58.
PMID: 38689308 PMC: 11059661. DOI: 10.1186/s12902-024-01585-6.